Literature DB >> 24379209

Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores.

Johanna Rivera1, Alfred Morgenstern, Frank Bruchertseifer, John F Kearney, Charles L Turnbough, Ekaterina Dadachova, Arturo Casadevall.   

Abstract

Radioimmunotherapy (RIT) takes advantage of the specificity and affinity of the antigen-antibody interaction to deliver microbicidal radioactive nuclides to a site of infection. In this study, we investigated the microbicidal properties of an alpha particle-emitting 213Bi-labeled monoclonal antibody (MAb), EA2-1 (213Bi-EA2-1), that binds to the immunodominant antigen on Bacillus anthracis spores. Our results showed that dormant spores were resistant to 213Bi-EA2-1. Significant spore killing was observed following treatment with EA2-1 labeled with 300 μCi 213Bi; however, this effect was not dependent on the MAb. In contrast, when spores were germinating, 213Bi-EA2-1 mediated MAb-specific killing in a dose-dependent manner. Dormant spores are very resistant to RIT, and RIT should focus on targeting vegetative cells and germinating spores.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24379209      PMCID: PMC3957843          DOI: 10.1128/AAC.01266-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Antibody-targeted radiation cancer therapy.

Authors:  Diane E Milenic; Erik D Brady; Martin W Brechbiel
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

2.  Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells.

Authors:  Ruth A Bryan; Zewei Jiang; Alfred Morgenstern; Frank Bruchertseifer; Arturo Casadevall; Ekaterina Dadachova
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

3.  Modeling the host response to inhalation anthrax.

Authors:  Judy Day; Avner Friedman; Larry S Schlesinger
Journal:  J Theor Biol       Date:  2011-02-03       Impact factor: 2.691

4.  Monoclonal antibodies for Bacillus anthracis spore detection and functional analyses of spore germination and outgrowth.

Authors:  Melissa K Swiecki; Mark W Lisanby; Fengyu Shu; Charles L Turnbough; John F Kearney
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

5.  Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility.

Authors:  C Rick Lyons; Julie Lovchik; Julie Hutt; Mary F Lipscomb; Eugenia Wang; Sara Heninger; Lucy Berliba; Kristin Garrison
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax.

Authors:  Johanna Rivera; Antonio S Nakouzi; Alfred Morgenstern; Frank Bruchertseifer; Ekaterina Dadachova; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

Review 7.  Anthrax toxin.

Authors:  R John Collier; John A T Young
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

Review 8.  Targeting the virus with radioimmunotherapy in virus-associated cancers.

Authors:  Ekaterina Dadachova; Xing-Guo Wang; Arturo Casadevall
Journal:  Cancer Biother Radiopharm       Date:  2007-06       Impact factor: 3.099

Review 9.  The Bacillus anthracis spore.

Authors:  Adam Driks
Journal:  Mol Aspects Med       Date:  2009-08-13

10.  Bacillus anthracis spore interactions with mammalian cells: relationship between germination state and the outcome of in vitro.

Authors:  Ian M Gut; Batcha Tamilselvam; Angela M Prouty; Bojana Stojkovic; Stephanie Czeschin; Wilfred A van der Donk; Steven R Blanke
Journal:  BMC Microbiol       Date:  2011-02-28       Impact factor: 3.605

View more
  3 in total

Review 1.  Radioimmunotherapy as a Novel Approach in HIV, Bacterial, and Fungal Infectious Diseases.

Authors:  Muath Helal; Ekaterina Dadachova
Journal:  Cancer Biother Radiopharm       Date:  2018-08-22       Impact factor: 3.099

2.  Radiolabeled antibodies for therapy of infectious diseases.

Authors:  Ekaterina Dadachova; Arturo Casadevall
Journal:  Microbiol Spectr       Date:  2014-11

3.  The potential of radioimmunotherapy as a new hope for HIV patients.

Authors:  Dina Tsukrov; Ekaterina Dadachova
Journal:  Expert Rev Clin Immunol       Date:  2014-05       Impact factor: 4.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.